FTC sues important pharmacy profit professionals over insulin price ranges The company brought motion against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of lifetime-saving insulin prescription drugs. Insurers will keep on vertically integrating to maintain more revenue in-household, and https://aya-healthcare-address53197.full-design.com/healthcare-news-an-overview-73267098